Search research articles
Contact Us
Filters
Showing results (111-120 of 166) with videos related to
Page
of 17
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
April 3, 2012
PROKR2 variants in multiple hypopituitarism with pituitary stalk interruption
Rachel Reynaud, Sujatha A Jayakody, Carine Monnier, et al.
Journal of Neuro-Oncology
|
May 28, 2015
Combined treatment by octreotide and everolimus: Octreotide enhances inhibitory effect of everolimus in aggressive meningiomas
Thomas Graillon, Céline Defilles, Amira Mohamed, et al.
Pituitary
|
January 12, 2021
Characterization of the ability of a, second-generation SST-DA chimeric molecule, TBR-065, to suppress GH secretion from human GH-secreting adenoma cells
Thomas Cuny, Thomas Graillon, Célines Defilles, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 22, 2022
Predictive Factors of Somatostatin Receptor Ligand Response in Acromegaly-A Prospective Study
Mirela-Diana Ilie, Antoine Tabarin, Alexandre Vasiljevic, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 6, 2015
Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases
Aurélien Archier, Arthur Varoquaux, Philippe Garrigue, et al.
International Journal of Molecular Sciences
|
July 24, 2021
Somatotroph Tumors and the Epigenetic Status of the <i>GNAS</i> Locus
Pauline Romanet, Justine Galluso, Peter Kamenicky, et al.
Neuro-Oncology Practice
|
November 27, 2023
Radio-chemotherapy feasibility for biopsy-only unresectable <i>IDH</i> wild-type glioblastomas (BO-GBM)
Vincent Harlay, Romain Appay, Céline Bequet, et al.
Oncotarget
|
April 29, 2017
Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs?
Amira Mohamed, David Romano, Alexandru Saveanu, et al.
Journal of Neuro-Oncology
|
October 16, 2025
Autonomy duration in patients with biopsy-only unresectable IDH wild-type glioblastomas
Vincent Harlay, Céline Bequet, Romain Appay, et al.
Neuro-Oncology Advances
|
July 10, 2020
Brief CommunicationCirculating tumor DNA is present in the most aggressive meningiomas
Thomas Graillon, Catherine Roche, Noémie Basset, et al.
Page
of 17
Search research articles
Search
Showing results (111-120 of 166) with videos related to
Sort By:
Page
of 17
The Journal of Clinical Endocrinology and Metabolism
|
April 3, 2012
PROKR2 variants in multiple hypopituitarism with pituitary stalk interruption
Rachel Reynaud, Sujatha A Jayakody, Carine Monnier, et al.
Journal of Neuro-Oncology
|
May 28, 2015
Combined treatment by octreotide and everolimus: Octreotide enhances inhibitory effect of everolimus in aggressive meningiomas
Thomas Graillon, Céline Defilles, Amira Mohamed, et al.
Pituitary
|
January 12, 2021
Characterization of the ability of a, second-generation SST-DA chimeric molecule, TBR-065, to suppress GH secretion from human GH-secreting adenoma cells
Thomas Cuny, Thomas Graillon, Célines Defilles, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 22, 2022
Predictive Factors of Somatostatin Receptor Ligand Response in Acromegaly-A Prospective Study
Mirela-Diana Ilie, Antoine Tabarin, Alexandre Vasiljevic, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 6, 2015
Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases
Aurélien Archier, Arthur Varoquaux, Philippe Garrigue, et al.
International Journal of Molecular Sciences
|
July 24, 2021
Somatotroph Tumors and the Epigenetic Status of the <i>GNAS</i> Locus
Pauline Romanet, Justine Galluso, Peter Kamenicky, et al.
Neuro-Oncology Practice
|
November 27, 2023
Radio-chemotherapy feasibility for biopsy-only unresectable <i>IDH</i> wild-type glioblastomas (BO-GBM)
Vincent Harlay, Romain Appay, Céline Bequet, et al.
Oncotarget
|
April 29, 2017
Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs?
Amira Mohamed, David Romano, Alexandru Saveanu, et al.
Journal of Neuro-Oncology
|
October 16, 2025
Autonomy duration in patients with biopsy-only unresectable IDH wild-type glioblastomas
Vincent Harlay, Céline Bequet, Romain Appay, et al.
Neuro-Oncology Advances
|
July 10, 2020
Brief CommunicationCirculating tumor DNA is present in the most aggressive meningiomas
Thomas Graillon, Catherine Roche, Noémie Basset, et al.
Page
of 17